Email this article RECOMBINANT FRAGMENTS OF CONSERVATIVE PROTEINS OF GROUP B STREPTOCOCCI AS A BASIS OF SPECIFIC VACCINE
- Authors: Suvorov A.N1, Grabovskaya K.B1, Leontyeva G.F1, Meringova L.F1, Koroleva I.N1, Duplik N.V1, Totolyan A.A1
-
Affiliations:
- Research Institute of Experimental Medicine, Saint-Petersburg, Russia
- Issue: Vol 87, No 2 (2010)
- Pages: 44-50
- Section: Articles
- URL: https://microbiol.crie.ru/jour/article/view/13436
- ID: 13436
Cite item
Full Text
Abstract
Aim. The study devoted to problem of using of recombinant fragments of group B streptococci (GBS) conservative proteins for induction of immune response against streptococcal infections. Two recombinant polypeptides (ScaAB and ScpB1) corresponding to immunogenic epitopes of two surface GBS proteins ScaAB and C5a-peptidase, which are presented in other streptococcal species, were studied. The objective of the study was to assess specificity and protective activity of mentioned polypeptides against homologous and heterologous strains of pathogenic streptococci from different groups. Materials and methods. Strains of Streptococcus pyogenes , Streptococcus pneumoniae, Streptococcus agalactiae were used in the study. Array of used methods included opsonophagocytic test as well as active and passive protection of experimental animals against streptococcal infection. Results. It was shown that antibodies specific to studied polypeptides opsonized several strains of group A and B streptococci as well as pneumococci. Immunization of mice with ScpB1 polypeptide resulted in more rapid recovery of animals from challenge systemic group B streptococcal infection. Antisera specific to both polypeptides provided passive protection of animals from infection caused either GBS or GAS. Conclusion. Obtained data confirm the feasibility to use recombinant fragments of several GBS conservative proteins in vaccine for induction of protection against infections caused by different species of pathogenic streptococci.
Full Text
РЕКОМБИНАНТНЫЕ ФРАГМЕНТЫ КОНСЕРВАТИВНЫХ БЕЛКОВ СТРЕПТОКОККОВ ГРУППЫ В КАК ОСНОВА СПЕЦИФИЧЕСКОЙ ВАКЦИНЫ×
About the authors
A. N Suvorov
Research Institute of Experimental Medicine, Saint-Petersburg, Russia
K. B Grabovskaya
Research Institute of Experimental Medicine, Saint-Petersburg, Russia
G. F Leontyeva
Research Institute of Experimental Medicine, Saint-Petersburg, Russia
L. F Meringova
Research Institute of Experimental Medicine, Saint-Petersburg, Russia
I. N Koroleva
Research Institute of Experimental Medicine, Saint-Petersburg, Russia
N. V Duplik
Research Institute of Experimental Medicine, Saint-Petersburg, Russia
A. A Totolyan
Research Institute of Experimental Medicine, Saint-Petersburg, Russia
References
- Ашмарин И.П. Васильев Н.Н. Амбросов В.А. Быстрые методы статистической обработки и планирование экспериментов. Л. ЛГУ, 1974.
- Грабовская К.Б., Леонтьева Г.Ф., Мерингова Л.Ф. и др. Протективные свойства некоторых поверхностных белков стрептококков группы В. Журн. микробиол. 2005, 5: 44-51.
- Дуплик Н.В., Королева И.В., Суворов А.Н. Клонирование, экспрессия и изучение иммунологических свойств рекомбинантного полипептида на основе С5а пептидазы стрептококка группы В. Микробиолия. 2009, 11 (1):7-14.
- Леонтьева Г.Ф., Суворов А.Н., Мерингова Л.Ф. и др. Экспериментальная оценка рекомбинантных полипептидов как вакцины против стрептококков группы В. Журн. микробиол. 2005, 2: 35-40.
- Суворов А.Н., Грабовская К.Б., Леонтьева Г.Ф. и др. Рекомбинантные вакцины против стрептококков группы В как средство специфической профилактики. Мед. акад. журн. 2006, 1: 13-19.
- Тотолян А.А., Суворов А.Н., Дмитриев А.В. Стрептококки группы В в патологии человека. СПб, Человек, 2009.
- Baker C.J., Edwards M.S. Group B streptococcal conjugate vaccines. Arch.Dis. Child. 2003, 88: 375-378.
- Chmouryguina I., Suvorov A., Ferrieri P. et al. Conservation of the C5a peptidase genes in group A and B streptococci. Infect.Immun. 1996, 64: 2387-2390.
- Dmitriev A., Tkachikova L., Suvorov A. et аl. Comparative genetic study of Group B streptococcal strains of human and bovine origin. Folia Microbiоl. 1999, 44 (4): 449-453.
- Gutekunst H., Eikmann B.J., Reinscheid D.J. et al. The novel fibrinogen-binding protein FbsB promotes Streptococcus agalactiae invasion into epithelial cess. Infect.Immun. 2004, 72: 3495- 3541.
- Lindahl G., M. Stålhammar-Carlemalm, T. Areschoug. Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens. Clin. Microbiol. Rev. 2005, 18: 102-127.
- Marques M.B., Kasper D.L., Shroff A. et al. Functional activity of antibodies to the group B polysaccharide of group B streptococci elicited by polysaccharide-protein conjugate vaccine. Infect. Immun. 1994, 62: 1593-1599.
- Spellerberg B., RodzinskiE., Martin S. et al. Lmb, a protein with a similarities to the Lra1 adhesin family, mediates attachment of Streptococcus agalactiae to human laminin. Ibid. 1999, 67: 871-878.
- Vorobieva E.I., Meringova L.F., Leontieva G.F. et al. Analysis of recombinant group B streptococcal protein ScaAB and evaluation of its immunogenicity. Folia Microbiol. 2005, 3: 172-176.
- Zhou Z-H., Tzioufas A.G., Notkins A.L. Properties and function of polyreactive antibodies and polyreactive antigen-inding B cells. J. Autoimmun. 2007, 29 (4): 219-228.
Supplementary files
